PLAT and Stroke: Although the incidence of sICH was lower in the patients who received placebo compared to those given t-PA in the National Institute of Neurological Disorders and Stroke (NINDS) trial (0.6 vs. 6.4%), management of acute stroke remains challenging, considering the vast number of stroke patients without intravenous thrombolysis worldwide (18).